The SARS-CoV-2 strain (registration number 43326) used in this study was isolated from a Korean patient traveling to China (the National Culture Collection for Pathogens) (Cheongju, Korea). Following plaque purification of SARS-CoV-2, this virus was cultivated twice in VERO cells with Dulbecco’s minimum essential medium (Welgene Inc., Daegu, Korea) containing 2% fetal bovine serum and 1% penicillin (10,000 IU/ml)/streptomycin (10,000 IU/ml) (Gibco, NY, United States) at 37°C in a 5% CO2 incubator. At 3 days postinoculation (dpi), the cell supernatant was collected, centrifuged at 3,000 g for 10 min, and stored at −80°C. Virus titration was performed using VERO cells, and the 50% tissue culture infectious dose 50/ml (TCID50/ml) was calculated according to the Reed–Muench method (Reed and Muench, 1938).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.